CClinicalTrials.gg
Active, not recruitingNCT05695599Updated Dec 10, 2024

Whole Body Vibration After Bariatric Surgery

An interventional study of Whole body vibration training in Bariatric Surgery and Whole Body Vibration Training and Bariatric Surgery, sponsored by Universidad de Zaragoza. Active, not recruiting at 2 sites in Spain. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-10.

Sponsored by Universidad de Zaragoza · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Morbid obesity is defined as a complex chronic condition in which a person presents a body mass index above 40 kg/m2. This disease increases the risk of several co-morbidities and entails a reduction in life expectancy of 10 years. Its prevalence is increasing in developed countries and bariatric surgery has been suggested to be one of the best tools to counteract it. Nonetheless, this surgery also presents negative effects such as loss of bone mineral density (BMD) and muscle mass and an increased fracture risk. The aim of the present study is to elucidate the effects of surgery and a whole body vibration training (WBV) on body composition, physical fitness, microbiota and cardiometabolic markers. Twenty eight participants will undergo bariatric surgery and will be randomly allocated into a control group or a WBV group. The whole body vibration group will have a duration of 4 months in which participants will train three times per week (30 minutes per session). Measurements of body composition (dual energy x-ray and peripheral quantitative computed tomography), physical fitness (muscular strength, aerobic fitness and balance), gait biomechanics, cardiometabolic markers, gut microbiota, quality of life and physical activity levels will be registered in four different timepoints (1. Before the intervention, 2) 45 days after the surgery, 3) Six months after the surgery, and 4) 18 months after the surgery. The cost of the surgery and the exercise program will also be calculated to perform a cost-effectiveness analysis.

02

Conditions studied

  • Bariatric Surgery and Whole Body Vibration Training
  • Bariatric Surgery
03

In context

Lead sponsor

Universidad de Zaragoza is the lead sponsor of 109 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients that are going to undergo Roux-en-Y gastric bypass with a Body mass index above 40 and below 180 kg.
  • With an age between 18 and 50 years of age
  • Living in the city of Zaragoza

Exclusion criteria

Exclusion Criteria:

  • History of cancer in the last 5 years
  • Have a pacemaker or being diagnosed with a cardiac problem that disables the participant to take place in an exercise program
  • To have suffered an acute myocardial infarction in the last 6 months
  • To present uncontrolled hypertension
  • Fracture in the last year
  • Any other condition that the physician deems as a contraindication for performing supervised physical exercise
  • Menopause
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    Whole body vibration

    Participants will undergo a whole body vibration training

    Device: Whole body vibration training

  • No intervention
    Control Group

    Participants will not perform an intervention

Interventions

  • DeviceWhole body vibration training

    3 times per week of 20 to 30 minute sessions during 16 weeks of training

    Also known as: Exercise

06

What researchers measure

Primary outcomes

  1. Bone mineral density

    Bone density measured with dual energy x-ray

    Time frame: pre-surgery

  2. Bone mineral density

    Bone density measured with dual energy x-ray

    Time frame: 2 months post-surgery

  3. Bone mineral density

    Bone density measured with dual energy x-ray

    Time frame: 6 months post-surgery

  4. Bone mineral density

    Bone density measured with dual energy x-ray

    Time frame: 18 months post-surgery

  5. Bone structure

    Radius strength and structure measured with peripheral quantitative computed tomography

    Time frame: pre-surgery

  6. Bone structure

    Radius strength and structure measured with peripheral quantitative computed tomography

    Time frame: 2 months post-surgery

  7. Bone structure

    Radius strength and structure measured with peripheral quantitative computed tomography

    Time frame: 6 months post-surgery

  8. Bone structure

    Radius strength and structure measured with peripheral quantitative computed tomography

    Time frame: 18 months post-surgery

  9. Body composition

    Body fat and visceral adipose tissue measured with Dual energy X-ray

    Time frame: pre-surgery

  10. Body composition

    Body fat and visceral adipose tissue measured with Dual energy X-ray

    Time frame: 2 months post-surgery

  11. Body composition

    Body fat and visceral adipose tissue measured with Dual energy X-ray

    Time frame: 6 months post-surgery

  12. Body composition

    Body fat and visceral adipose tissue measured with Dual energy X-ray

    Time frame: 18 months post-surgery

  13. Fecal gut microbiota

    Stool specimens will be taken. Samples will be sequenced by Shallow Shotgun Metagenomic sequencing using Illumina Sequencing PE150 (5 G raw data per sample).

    Time frame: pre-surgery

  14. Fecal gut microbiota

    Stool specimens will be taken. Samples will be sequenced by Shallow Shotgun Metagenomic sequencing using Illumina Sequencing PE150 (5 G raw data per sample).

    Time frame: 6 months post-surgery

  15. Fecal gut microbiota

    Stool specimens will be taken. Samples will be sequenced by Shallow Shotgun Metagenomic sequencing using Illumina Sequencing PE150 (5 G raw data per sample).

    Time frame: 18 months post-surgery

Secondary outcomes

  1. Basal metabolic rate

    Basal metabolic rate

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  2. Heart rate variability

    Heart rate variability measured in fasting and resting conditions

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  3. Aerobic capacity

    Bruce protocol on a treadmill

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  4. Muscular strength of the upper limbs

    Measured with a handgrip dynamometer

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  5. Muscular strength of the lower limbs

    Measured with the stand and sit chair test

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  6. Agility

    Measured with the time up and go test. Sitting on a chair the participant has to stand up and walk 2,4 meters forward, turn and sit back on the chair.

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  7. Balance

    Measured with the SPPB battery in three different position (feet together, tandem, semi tandem)

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  8. Gait kinematics

    Gait kinematics measured with inertial sensors

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  9. Frailty status

    SPPB measures

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  10. Quality of life of participants SF36

    Quality of life measured with the SF36

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  11. Quality of life of participants EUROQOL 5Q

    Quality of life measured with the EUROQOL 5Q

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  12. Pain scale

    Pain measured with the WOMAC questionnaire

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  13. Objective physical activity levels

    Physical activity levels registered with triaxial accelerometers that they will wear during 7 days.

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  14. Physical activity levels

    Physical activity levels measures with IPAQ-short

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  15. Ankle range of motion

    Measurement of dorsiflexion and plantar flexion

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  16. Inflammatory markers

    Interleukin 6, TNF alpha, and reactive C protein

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  17. Blood glucose

    Glucose levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  18. Cholesterol

    Blood cholesterol levels (LDL and HDL)

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  19. Insulin resistance

    HOMA test and insulin levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  20. Kidney markers

    Creatinine levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  21. Liver function (ALT)

    Alanine transaminase levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  22. Liver function (AST)

    Aspartate transaminase

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  23. Liver function (ALP)

    Alkaline phosphatase

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  24. Liver function (GGT)

    Gamma-glutamyl transferase

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  25. Liver function (bilirubin)

    Serum bilirubin levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  26. International normalised ratio test

    INR coagulation

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  27. Albumin levels

    Serum albumin levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  28. Iron metabolism

    Iron metabolism markers

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  29. Vitamin B12 levels

    Plasma vitamin B12 levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  30. Folic acid levels

    Plasma folic acid levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  31. Hydroxyvitamin D

    Plasma Hydroxyvitamin D levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  32. Calcium

    Plasma calcium levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  33. Phosphorus

    Plasma phosphorus levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  34. Parathyroid hormone

    Parathyroid hormone plasma levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  35. Bone alkaline phosphatase

    Bone alkaline phosphatase plasma levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  36. Leptin

    Leptin plasma levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  37. Adinopectin

    Adinopectin plasma levels

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

  38. Diet

    Diet will be assessed though a food frequency questionnaire

    Time frame: pre-surgery, 6 months post-surgery

  39. Depression, anxiety and stress questionnaire

    Dass 21 scale

    Time frame: pre-surgery, 2 months post-surgery, 6 months post-surgery and 18 months post-surgery

07

Study locations

2 sites
  • GENUD Research group
    Zaragoza, 50009, Spain
  • Hospital Clinic Universitario
    Zaragoza, 50012, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05695599
Lead sponsor
Universidad de Zaragoza
Collaborators
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBEROBN)
Responsible party
José A. Casajús (Professor, Universidad de Zaragoza) — Principal investigator
First posted
Jan 25, 2023
Start date
Apr 23, 2023
Primary completion
Dec 31, 2025 (estimated)
Completion
Jul 6, 2026 (estimated)
Last update
Dec 10, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion